ICAGEN, INC.

DURHAM, NC · Biotech · Acquired

Selective chelation molecule for systemic cesium-137 decorporation in blood and muscle

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Biotech
Headquarters: DURHAM, NC
Latest Form D: $7.3M, Sep 2018
Total capital: $19M

Federal grants: $300K; 1 award · 2015; Rank in peer group#8 of 392
Private capital raised: $17.1M; 9 Form D · last Sep 2018; 98 months since last filing
Federal contracts: $1.6M; 7 awards · Defense, Health and Human S; Rank in Biotech#153 of 4373
Granted patents: 15; 25 pending · first 2009; Rank in peer group#8 of 392

Capital timeline

Latest events

Sep 2018Private capital raisedForm D · SEC · 9th filing$7.3M
Aug 2018Private capital raisedForm D · SEC · 8th filing$500K
Apr 2018Private capital raisedForm D · SEC · 7th filing$2M
May 2017Private capital raisedForm D · SEC · 6th filing$2M
Apr 2017Private capital raisedForm D · SEC · 5th filing$1.5M
Jul 2016Private capital raisedForm D · SEC · 4th filing$1.1M
Sep 2015Federal contractHealth and Human S · Igf::ot::igf SBIR Phase I Topic 339 Systemic Targeted Radionuclide Therapy For Cancer Treatment Period Of Performance: 09/22/2015 - 06/21/2016$300K
Dec 2014Private capital raisedForm D · SEC · 3rd filing$49K
Apr 2013Private capital raisedForm D · SEC · 2nd filing$1.6M
May 2011Private capital raisedForm D · SEC · 1st filing$1.1M

Show 7 earlier federal awards

Jul 2015Federal grantHealth and Human S · Phase I · XRpro Radioactive Cesium Decorporation Agents$300K
Aug 2012Federal contractDefense · SBIR Phase I$150K
Sep 2009Federal contractDefense · Scientific Research Services$100K
Sep 2009Federal contractDefense · Scientific Research Services$100K
Feb 2009Federal contractDefense · Biomolecular Taggants For Covert Tracking And Watermarking$736K
Jan 2008Federal contractDefense · Biomolecular Taggants For Covert Tracking And Watermarking$100K
Aug 2006Federal contractDefense · STTR Phase I Erms Log # 06188006$100K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

57months

from ICAGEN, INC.’s first federal award to its first private round.

First federal award · Aug 2006: Defense · $100K
First Form D · May 2011: $1.1M · 1st Form D
Awards before first raise: 5 awards

An association in public records, not a cause or a prediction.

Standing among 392 peers

Line = median

Biotech · Molecule

Federal grants#8 · top 2%
Granted patents#8 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Benjamin WarnerResearcherDirectorLinked by 3 patents
Clive KabatznikDirectorNamed in SEC Form D filings
Douglas KrafteExecutive OfficerNamed in SEC Form D filings
Edward RoffmanDirectorNamed in SEC Form D filings
Mark KorbExecutive OfficerNamed in SEC Form D filings
Michael TaglichDirectorNamed in SEC Form D filings

Show all 9 people

Richard CunninghamExecutive OfficerNamed in SEC Form D filings
Timothy TysonDirectorNamed in SEC Form D filings
Vincent PalmieriDirectorNamed in SEC Form D filings

What it has protected

USPTO · 15 granted of 40

Jan 24, 2023GrantedMethod And Apparatus For Measuring Protein Post-translational ModificationUSPTOUS 11,561,188
Mar 3, 2020GrantedMethod And Apparatus For Measuring Protein Post-translational ModificationUSPTOUS 10,577,642
Jan 7, 2020GrantedSensors And Sensor Arrays For Detection Of AnalytesUSPTOUS 10,527,600

Show all 40 patent records

Method And Apparatus For Measuring Protein Post-translational ModificationJan 24, 2023 · US 11,561,188Granted
Method And Apparatus For Measuring Protein Post-translational ModificationMar 3, 2020 · US 10,577,642Granted
Sensors And Sensor Arrays For Detection Of AnalytesJan 7, 2020 · US 10,527,600Granted
Method For Analysis Using X-ray FluorescenceOct 29, 2019 · US 10,458,933Granted
Methods For Measuring Analyte Transport Across Barriers Using X-ray FluorescenceSep 25, 2018 · US 10,082,511Granted
Method for Analysis Using X-Ray FluorescenceSep 25, 2018 · US 10,082,474Granted
Method and Apparatus for Measuring Protein Post-Translational ModificationMay 22, 2018 · US 9,976,172Granted
Method For Measuring Analyte Transport Across Cell Membranes Using X-ray FluorescenceNov 29, 2016 · US 9,506,931Granted
Well PlateOct 25, 2016 · US 9,476,846Granted
Method For Analysis Using X-ray FluorescenceSep 13, 2016 · US 9,442,085Granted
Method For Analysis Using X-ray FluorescenceSep 6, 2016 · US 9,435,756Granted
Method For Analysis Using X-ray FluorescenceMay 10, 2016 · US 9,335,284Granted
Heterocycles As Potassium Channel ModulatorsApr 28, 2015 · US 9,018,208Granted
Sulfonamide DerivativesDec 9, 2014 · US 8,907,101Granted
Sodium Channel InhibitorsDec 4, 2014 · Application 14459601Pending
Flow Method And Apparatus For Screening Chemicals Using Micro X-ray FluorescenceApr 14, 2009 · US 7,519,145Granted
Sulfone-containing ProdrugsApplication PCTUS2005018134Pending
Polycyclic Pyridines As Potassium Ion Channel ModulatorsApplication PCTUS2005012524Pending
Fused Ring Heterocycles As Potassium Channel ModulatorsApplication PCTUS2004029868Pending
Asymmetric Benzimidazoles And Related Compounds As Potassium Channel ModulatorsApplication PCTUS2004015155Pending
Method For Screening Compounds Using Consensus SelectionApplication PCTUS2004001984Pending
Quinazolinones As Potassium Channel ModulatorsApplication PCTUS2003041657Pending
Sulfonamides As Potassium Channel BlockersApplication PCTUS2003025587Pending
Bis-benzimidazoles And Related Compounds As Potassium Channel ModulatorsApplication PCTUS2003015225Pending
Methods For Treating Diseases Related To Intraocular PressureApplication PCTUS2003006145Pending
Pyrimidines As Novel Openers Of Potassium Ion ChannelsApplication PCTUS2002039099Pending
Method For Producing Chemical Libraries Enhanced With Biologically Active MoleculesApplication PCTUS2002038429Pending
PyrazolopyrimidinesApplication PCTUS2002035171Pending
PiperidinesApplication PCTUS2002035173Pending
Pyrazole-amides And-sulfonamidesApplication PCTUS2002035172Pending
Bisarylamines As Potassium Channel OpenersApplication PCTUS2002007744Pending
Method For Screening CompoundsApplication PCTUS2002005707Pending
Pyridine-substituted Benzanilides As Potassium Ion Channel OpenersApplication PCTUS2002003061Pending
Methods Of Detection Using X-ray FluorescenceApplication PCTUS2018051025Pending
Methods And Apparatus For Measuring Metals And MetalloidsApplication 62324057Pending
Heterocycles As Potassium Channel ModulatorsApplication PCTUS2011023444Pending
Treatment Methods Using Triaryl Methane CompoundsApplication PCTUS2010048815Pending
Inhibitors Of Ion ChannelsApplication PCTUS2009057509Pending
Heterocycles As Potassium Channel ModulatorsApplication PCTUS2008073519Pending
Sodium Channel InhibitorsApplication PCTUS2008070018Pending

Strand Therapeutics Inc.Similar federal contract value in Biotech · $1.6M in contracts
MAKSCIENTIFICSimilar federal contract value in Biotech · $1.6M in contracts
INAEDIS, INCSimilar federal contract value in Biotech · $1.6M in contracts
PRESSURE BIOSCIENCES, INC.Similar federal contract value in Biotech · $1.6M in contracts
SOLARIS VACCINES, INC.Similar federal contract value in Biotech · $1.5M in contracts
Arytha Biosciences, LLCSimilar federal contract value in Biotech · $1.5M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.